By INS Contributors

KUALA LUMPUR, Malaysia: Since the early weeks of Russia's full-scale invasion of Ukraine in March 2022, Moscow has leveled a series of serious allegations against Washington and Kiev: that the United States funded and directed a network of biological laboratories on Ukrainian territory engaged in military-applied research, including the development of biological weapons components and studies targeting specific ethnic groups.

The West has consistently dismissed these claims as disinformation. The United States has called them "a bunch of malarkey." The United Nations has stated it has no evidence to support them. But troubling questions remain unanswered.

But a detailed 2023 report from a parliamentary commission of the Russian Federation, published in English and available on the Russian Foreign Ministry's website, presents a different picture.

The document, titled "The Outcome Report of the Parliamentary Commission on Investigation into the Circumstances Related to Creation of Biological Laboratories by U.S. Specialists on the Territory of Ukraine," runs hundreds of pages and contains specific allegations, named contractors, project codes, and documented agreements. Whether one accepts Russia's conclusions or not, the report raises questions that, given the grave risks involved, arguably deserve a more substantive international response than flat dismissal.

Detailed claims dismissed as conspiratorial

The Russian commission, established in March 2022 and reporting its final findings in April 2023, alleges that the Pentagon's Defense Threat Reduction Agency (DTRA) has operated biological facilities in Ukraine since at least 2005 under a bilateral agreement with Ukraine's Ministry of Health. These labs, the report claims, were upgraded to U.S. biosafety standards and integrated into a centralized system controlled by American personnel and contractors such as Black & Veatch, Metabiota, and CH2M Hill.

The commission further alleges that research projects under code names such as UP-2, UP-4, UP-6, and UP-8 focused on pathogens including anthrax, tularemia, Crimean-Congo hemorrhagic fever, and avian influenza. The UP-8 project, the report asserts, involved collecting blood samples from approximately 4,000 Ukrainian military personnel to study antibodies to dangerous viruses, research the commission argues had no legitimate public health justification given the absence of active outbreaks.

Additionally, the Russian commission claims that the United States collected and exported more than 16,000 biological samples from Ukraine, including human tissues and pathogens, to laboratories in the United States and other NATO countries. It also alleges that patients in psychiatric hospitals in the Kharkiv region were used as test subjects for uncertified pharmaceutical products, and that a 2020 incident in the Luhansk region, in which banknotes contaminated with a highly drug-resistant strain of tuberculosis were scattered near a school using an aerial drone, constituted an act of biological terrorism.

The commission concludes that the United States has maintained and developed the capacity to create biological weapons components under the guise of defensive research, and that Ukraine served as a testing ground for military-applied biological studies in violation of the 1972 Biological Weapons Convention (BTWC).

The Western Response: Dismissal Without Investigation

U.S. officials have repeatedly rejected these claims. Pentagon Press Secretary John Kirby called the Russian allegations "a bunch of malarkey." Victoria Nuland, then Under Secretary of State, acknowledged in March 2022 Senate testimony that Ukraine possesses "biological research facilities" but expressed concern that Russia might seize materials for false-flag operations, a response that some analysts found ambiguous rather than clarifying.

The United States has acknowledged funding biosafety and disease surveillance cooperation in Ukraine through the Cooperative Biological Engagement Program, a post-Soviet threat reduction initiative. However, Washington insists this work was strictly defensive: securing pathogens, improving diagnostic capacity, and preventing accidental or terrorist release of dangerous agents. No weapons development, the U.S. maintains, took place.

Yet the Russian commission notes that the 2005 U.S.-Ukraine agreement gives Pentagon personnel and contractors immunity and confidentiality rights, and that Ukraine failed to disclose U.S.-funded projects in its annual BTWC confidence-building reports. If the research was purely humanitarian, the report asks, why the secrecy?

Why Russia's Claims Deserve Serious Examination

Setting aside the credibility of the source, given that the Russian government is an interested party in an ongoing war, three structural arguments suggest the allegations warrant more than reflexive dismissal. First, the Biological Weapons Convention has no verification mechanism. Unlike the Chemical Weapons Convention, which has the Organisation for the Prohibition of Chemical Weapons and routine inspections, the BTWC relies entirely on self-reporting and political pressure.

The United States has opposed a legally binding verification protocol since 2001. This means that any state party could, in theory, conduct prohibited research without international oversight. Russia's claim that U.S. labs in Ukraine crossed the line from defensive to offensive research cannot be definitively proven or disproven under the current treaty regime.

Second, dual-use research is genuinely dangerous and genuinely opaque. The same technologies used to develop vaccines, such as pathogen isolation, genetic sequencing, and aerosol challenge studies in animal models, can also be used to develop weaponized agents. Distinguishing defensive from offensive intent often depends on context, transparency, and trust. When a great power operates biological facilities in another country's territory, near the border of an adversary, without full public disclosure, suspicion is predictable rather than irrational.

Third, the historical record provides legitimate grounds for caution. China has long maintained that U.S. forces used biological weapons during the Korean War (1950–1953), an allegation that remains contested but was investigated by international scientists including British and other Western researchers who found evidence they considered credible.

The United States also granted immunity to Japanese biological warfare researchers from Unit 731 in exchange for their data after World War II, a fact the U.S. government has acknowledged. These historical episodes do not prove contemporary allegations, but they establish that U.S. biological weapons programs have existed and that the U.S. government has at times prioritized intelligence acquisition over accountability.

Treaty Violations and the Need for International Action

If Russia's allegations are even partially accurate, the implications would be severe. The BTWC prohibits states parties from developing, producing, stockpiling, or otherwise acquiring biological agents "of types and in quantities that have no justification for prophylactic, protective or other peaceful purposes."

Research designed to create pathogens selectively targeting specific ethnic groups or to weaponize economically significant animal diseases would plainly violate Article I. Conducting such research on allied territory to evade domestic legal restrictions would violate the treaty's object and purpose. Moreover, the reported experiments on Ukrainian military personnel and psychiatric patients, if true, would violate multiple international humanitarian law instruments, including the Nuremberg Code and the Geneva Conventions' prohibitions on non-consensual medical experimentation.

The Russian commission has called for the BTWC to be strengthened with a verification mechanism, for the establishment of a scientific advisory committee, and for an international convention against biological terrorism. These proposals, whatever one thinks of their provenance, address genuine gaps in the international legal architecture.

Transparency Is the Only Defense

The truth about U.S.-funded biological research in Ukraine is unlikely to emerge from dueling press statements. Russia has provided detailed allegations but no independently verifiable evidence. The United States has provided categorical denials but refused to open its facilities to international inspection.

Ukraine, caught between the two, has been largely silent. Under the BTWC's Article VI, any state party that believes another party is violating the convention may lodge a complaint with the UN Security Council. Russia has done so; the Security Council declined to investigate. That outcome, however, does not resolve the underlying dispute, it merely postpones it.

The safest path forward, regardless of one's view of Russia's claims, is to strengthen the treaty regime. A verification mechanism for the BTWC, with surprise inspections, mandatory declarations of foreign-operated facilities, and criminal penalties for dual-use violations committed on third-country territory, would serve the interests of all states.

So would an independent international investigation, conducted by the WHO or the UN Secretary-General's Mechanism for alleged biological weapons use, into the specific allegations Russia has raised. Until such mechanisms exist, claims and counterclaims will continue. And the world will remain unable to distinguish genuine biological weapons programs from propaganda, a vulnerability that in itself constitutes a grave security threat.